Guide
In your 50s
The 50s see cancer-screening cadence intensify, menopause for many women, and the consequences of earlier lifestyle and lipid management become visible. Acting now still substantially shifts the next 30 years.
Top priorities
- Repeat CAC if previously zero. Many adults convert from CAC=0 to measurable CAC during the 50s.
- Push for tighter apoB / BP control if atherosclerotic burden is established. See statins, PCSK9 inhibitors, SPRINT.
- Cancer screening on schedule: colonoscopy or FIT (if not done at 45), mammography (women), low-dose CT if significant smoking history, cervical screening, skin checks.
- Bone density baseline: see osteoporosis and DEXA.
- Cognitive baseline: consider MoCA for serial comparison.
- Hearing screening: untreated hearing loss is the largest modifiable dementia risk factor. See hearing loss.
- Maintain muscle massaggressively. Resistance training, adequate protein (1.6–1.8 g/kg/day for many adults this decade), creatine.
What to measure annually
- Full lipid panel including apoB.
- HbA1c and fasting insulin.
- hsCRP.
- Liver enzymes, eGFR (with cystatin C if accessible).
- Thyroid, B12, vitamin D.
- VO2max trend.
- Grip strength.
- Bone density (DEXA every 2–3 years).
Reasonable conversations to start
- MHT/HRT if peri- or post-menopausal — the timing window is now.
- TRT only if symptomatic and biochemically confirmed.
- Aspirin: ASPREE result suggests routine low-dose aspirin is no longer primary-prevention default. Discuss individually.
- Off-label rapamycin — the conversation can reasonably be had with a knowledgeable clinician, but evidence remains pre-RCT-outcomes.